汤剂
肾
化学
药理学
代谢组学
甲状腺
松弛素
机制(生物学)
内分泌系统
药品
癌症
传统医学
激素
作用机理
生物活性
内科学
内分泌学
生物化学
肾癌
作者
Lina Zhong,Yumei Huang,Qiyuan Yang,Huijia Gan,Jiani Ren,Gaoyuan Xu,Jianbei TENG
摘要
This study aims to analyze secondary metabolites of Dendrobium fimbriatum via UPLC-MS/MS; establish hyperthyroidism-induced kidney yin deficiency model with thyroid tablets to study its decoction's effects; use UPLC-MS/MS untargeted metabolomics to screen blood-entry components, biomarkers, and potential active substances; explore component-target-pathway mechanism via network pharmacology and molecular docking. One hundred thirty-eight secondary metabolites are identified. Decoction increased rat body weight/pain threshold, reduced temperature; alleviated kidney yin deficiency symptoms/pathology; regulated thyroid (T3/T4), gonad (T/E2), and nucleotide (cAMP/cGMP) functions; and changed OPLS-DA profile; 13 blood-entry components, 30 biomarkers, and 9 potential "nourishing kidney yin" substances are found-four high-binding components act on EGFR/AKT1/SRC via cancer pathogenesis, endocrine resistance, and relaxin pathways. Decoction improves model rats' metabolism; four active components (e.g., N-p-coumaroyltyramine) regulate EGFR/AKT1/SRC via key pathways, affecting biomarkers and glycerophospholipid/amino acid/linoleic acid metabolism to exert anti-inflammatory/antioxidant/antitumor/antiapoptotic effects, realizing "nourishing kidney yin"; this study supports mechanism analysis, quality evaluation, and new drug R&D of D. fimbriatum.
科研通智能强力驱动
Strongly Powered by AbleSci AI